Protagonist Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $52M | 782k | 66.43 |
| 2025-03-31 | $27M | 556k | 48.36 |
| 2024-12-31 | $29M | 759k | 38.60 |
| 2024-09-30 | $37M | 822k | 45.00 |
| 2024-06-30 | $21M | 591k | 34.65 |
| 2024-03-31 | $15M | 525k | 28.93 |
| 2023-12-31 | $12M | 515k | 22.93 |
| 2023-09-30 | $7.8M | 467k | 16.68 |
| 2023-06-30 | $15M | 559k | 27.62 |
| 2023-03-31 | $11M | 460k | 23.00 |
| 2022-12-31 | $6.7M | 617k | 10.91 |
| 2022-06-30 | $5.0M | 632k | 7.91 |
| 2022-03-31 | $8.2M | 346k | 23.68 |
| 2021-12-31 | $4.2M | 124k | 34.21 |
| 2021-09-30 | $7.5M | 423k | 17.72 |
| 2021-03-31 | $11M | 414k | 25.90 |
| 2020-12-31 | $11M | 552k | 20.16 |
| 2020-09-30 | $4.3M | 222k | 19.55 |
| 2020-06-30 | $9.4M | 530k | 17.66 |
| 2019-12-31 | $142k | 20k | 7.05 |
| 2019-09-30 | $1.9M | 157k | 12.01 |
| 2019-06-30 | $291k | 24k | 12.09 |
| 2019-03-31 | $1.3M | 101k | 12.57 |
| 2018-12-31 | $188k | 28k | 6.71 |
| 2018-09-30 | $405k | 39k | 10.29 |
| 2018-06-30 | $557k | 83k | 6.72 |
| 2018-03-31 | $267k | 31k | 8.59 |
| 2017-12-31 | $615k | 30k | 20.80 |
| 2016-09-30 | $282k | 13k | 21.14 |